# Lexeo Therapeutics, Inc.: filings

LXEO · Nasdaq · CIK 1907108 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lxeo.md) · [Financials](/companies/lxeo/financials.md) · [Filings](/companies/lxeo/filings.md) · [Insiders](/companies/lxeo/insiders.md)

## Reports and events: 58 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 98, 144 42, 8-K 38, SCHEDULE 13G/A 28, 3 21, 424B3 15, SCHEDULE 13G 10, 10-Q 9, CORRESP 9, SC 13G 9, SC 13G/A 8, UPLOAD 8, EFFECT 6, S-8 5, DEFA14A 4, DRS/A 4, DRSLTR 4, 10-K 3, 424B5 3, ARS 3, DEF 14A 3, FWP 3, S-3 3, 4/A 2, S-1 2, S-1/A 2, SEC STAFF LETTER 2, 10-Q/A 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, POS AM 1, S-3/A 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 16:20 ET | [8-K](/filings/0001193125-26-407555.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-407555 |
| 2026-09-22 | 07:08 ET | [8-K](/filings/0001193125-26-397221.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-397221 |
| 2026-08-12 | 07:04 ET | [10-Q](/filings/0001193125-26-345724.md) | Quarterly report, period 2026-06-30 | 0001193125-26-345724 |
| 2026-08-12 | 07:02 ET | [8-K](/filings/0001193125-26-345722.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-345722 |
| 2026-06-29 | 17:06 ET | [8-K](/filings/0001193125-26-288703.md) | 5.07 Shareholder vote results | 0001193125-26-288703 |
| 2026-06-15 | 07:05 ET | [8-K](/filings/0001193125-26-270275.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-270275 |
| 2026-05-11 | 07:05 ET | [10-Q](/filings/0001193125-26-215678.md) | Quarterly report, period 2026-03-31 | 0001193125-26-215678 |
| 2026-05-11 | 07:03 ET | [8-K](/filings/0001193125-26-215674.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-215674 |
| 2026-04-30 | 07:01 ET | [DEF 14A](/filings/0001193125-26-193930.md) | Proxy statement, period 2025-12-31 | 0001193125-26-193930 |
| 2026-04-30 | 07:00 ET | [8-K](/filings/0001193125-26-193927.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-193927 |
| 2026-03-30 | 17:39 ET | [10-K](/filings/0001193125-26-132085.md) | Annual report, period 2025-12-31 | 0001193125-26-132085 |
| 2026-03-30 | 17:30 ET | [8-K](/filings/0001193125-26-131792.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-131792 |
| 2026-02-05 | 16:17 ET | [8-K](/filings/0001193125-26-039425.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-039425 |
| 2026-01-27 | 07:31 ET | [8-K](/filings/0001193125-26-023339.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-023339 |
| 2026-01-12 | 11:45 ET | [8-K](/filings/0001193125-26-010091.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-010091 |
| 2025-11-05 | 07:41 ET | [10-Q](/filings/0001193125-25-265757.md) | Quarterly report, period 2025-09-30 | 0001193125-25-265757 |
| 2025-11-05 | 07:38 ET | [8-K](/filings/0001193125-25-265755.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265755 |
| 2025-10-17 | 17:26 ET | [8-K](/filings/0001193125-25-242652.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-242652 |
| 2025-10-07 | 06:03 ET | [8-K](/filings/0001193125-25-232514.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-232514 |
| 2025-08-14 | 07:33 ET | [10-Q](/filings/0000950170-25-108427.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108427 |
| 2025-08-14 | 07:31 ET | [8-K](/filings/0000950170-25-108426.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-108426 |
| 2025-06-30 | 16:47 ET | [8-K](/filings/0000950170-25-091671.md) | 5.07 Shareholder vote results | 0000950170-25-091671 |
| 2025-05-27 | 07:32 ET | [8-K](/filings/0000950170-25-077377.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-077377 |
| 2025-05-15 | 18:22 ET | [10-Q/A](/filings/0000950170-25-071709.md) | Quarterly report, amended, period 2025-03-31 | 0000950170-25-071709 |
| 2025-05-12 | 07:03 ET | [10-Q](/filings/0000950170-25-068536.md) | Quarterly report, period 2025-03-31 | 0000950170-25-068536 |
| 2025-05-12 | 07:02 ET | [8-K](/filings/0000950170-25-068534.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-068534 |
| 2025-04-28 | 16:46 ET | [DEF 14A](/filings/0000950170-25-059375.md) | Proxy statement, period 2024-12-31 | 0000950170-25-059375 |
| 2025-04-07 | 06:06 ET | [8-K](/filings/0000950170-25-051345.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-051345 |
| 2025-03-24 | 07:03 ET | [10-K](/filings/0000950170-25-043486.md) | Annual report, period 2024-12-31 | 0000950170-25-043486 |
| 2025-03-24 | 07:01 ET | [8-K](/filings/0000950170-25-043485.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-043485 |
| 2025-01-13 | 07:35 ET | [8-K](/filings/0000950170-25-004566.md) | 8.01 Other events | 0000950170-25-004566 |
| 2024-12-19 | 07:01 ET | [8-K](/filings/0000950170-24-138224.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-138224 |
| 2024-11-13 | 07:33 ET | [10-Q](/filings/0000950170-24-125943.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125943 |
| 2024-11-13 | 07:31 ET | [8-K](/filings/0000950170-24-125940.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-125940 |
| 2024-10-30 | 06:15 ET | [8-K](/filings/0000950170-24-118569.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-118569 |
| 2024-10-09 | 16:30 ET | [8-K](/filings/0000950170-24-113764.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-113764 |
| 2024-08-12 | 07:02 ET | [10-Q](/filings/0000950170-24-095057.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095057 |
| 2024-08-12 | 07:01 ET | [8-K](/filings/0000950170-24-095054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095054 |
| 2024-07-15 | 07:55 ET | [8-K](/filings/0000950170-24-083386.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-083386 |
| 2024-07-08 | 07:01 ET | [8-K](/filings/0000950170-24-081942.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-081942 |
| 2024-06-28 | 07:33 ET | [8-K](/filings/0000950170-24-078774.md) | 5.07 Shareholder vote results | 0000950170-24-078774 |
| 2024-05-09 | 07:07 ET | [8-K](/filings/0000950170-24-056260.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056260 |
| 2024-05-09 | 07:02 ET | [10-Q](/filings/0000950170-24-056247.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056247 |
| 2024-04-26 | 07:55 ET | [DEF 14A](/filings/0000950170-24-048662.md) | Proxy statement, period 2023-12-31 | 0000950170-24-048662 |
| 2024-04-22 | 08:22 ET | [8-K](/filings/0000950170-24-046197.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-046197 |
| 2024-04-22 | 08:11 ET | [8-K](/filings/0000950123-24-003417.md) | 5.02 Departure or appointment of officers or directors | 0000950123-24-003417 |
| 2024-04-16 | 07:32 ET | [8-K](/filings/0000950170-24-044598.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-044598 |
| 2024-04-09 | 08:01 ET | [S-1](/filings/0001193125-24-090233.md) | Registration statement | 0001193125-24-090233 |
| 2024-03-11 | 16:11 ET | [8-K](/filings/0000950170-24-029249.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-029249 |
| 2024-03-11 | 09:29 ET | [10-K](/filings/0000950170-24-028941.md) | Annual report, period 2023-12-31 | 0000950170-24-028941 |

Page 1 of 2. [Older](/companies/lxeo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:31 ET. No prices; not investment advice.